Capitalisation Boursière Changement Date
Acadia Pharmaceuticals USD 3.57B 100M 2026-11
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Amgen USD 247.94B 20.06B 2026-11
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 10.95B 667M 2026-11
Cytokinetics USD 7.51B 1.66B 2026-11
Daiichi Sankyo JPY 5.22T 356.74B 2026-09
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 184.82B 27.96B 2026-09
Incyte USD 24.6B 1.95B 2026-09
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Karyopharm Therapeutics USD 126M 9M 2026-03
Novartis USD 292.09B 51.5B 2026-09
Pfizer USD 169.88B 6.47B 2026-11
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.65B 276M 2026-11
TG Therapeutics USD 8.41B 3.1B 2026-06
Ultragenyx Pharmaceutical USD 1.37B 108M 2026-11
Vertex Pharmaceuticals USD 142.88B 10.37B 2026-11
Xencor USD 2.14B 281M 2026-11